OsteoAid – the all-natural supplement targeting osteoporosis by Metabolics

Developed specifically for people with, or at risk of developing, osteoporosis, OsteoAid is a dietary supplement created and manufactured in the UK by Metabolics. Osteoporosis is a disease of the bones which causes them to become porous, weak and prone to fracture.

Bone mass density (BMD) begins to decrease in our early 20s. From 30 onwards most people have a decreased BMD. This means weaker bones and increased risk of fracture. Postmenopausal women are also at higher risk of osteoporosis due to their lower levels of oestrogen and progesterone which help to remove dead bone and build new bone respectively.

Genetic, hormonal and lifestyle factors, such as exercise also impact on BMD. Certain nutrients are also implicated in a bone support formula and these are included in OsteoAid.

The key ingredients of OsteoAid are:

• Beta carotene, a carotenoid substance naturally found in plants. It is accepted as an essential human nutrient, especially when there is a deficiency of vitamin A. There are two sources of vitamin A, retinol found in animal products and beta carotene found in carrots and deep green leafy vegetables. Excess intake of retinol is associated with a risk of osteoporosis and increased bone fracture, whereas high intake of beta carotene is not. It is thought that excessive amounts of vitamin A trigger an increase in bone breakdown and slow bone build up. Vitamin A also stimulates bone building cells to secrete a hormone which helps bind calcium into the bone matrix. There is a delicate balance between vitamin A and vitamin D3. Beta carotene is the precursor to make vitamin A and is considered safe and does not increase fracture risk. This is why we use beta carotene and not vitamin A in Metabolics products

• Magnesium, in the most bioavailable citrate form. 50% of the body’s Magnesium is found in the bones. Magnesium is required for:

• The absorption and metabolism of calcium
• The conversion of vitamin D to stimulate the thyroid’s production of the hormone calcitonin that slows bone resorption
• Regulating parathyroid hormone, a regulator of bone breakdown
• Activating the enzyme required for production of new bone
• Regulating calcium transport

• Vitamin B12 as methylcobalamin, the form in which vitamin B12 is most easily transported across cell membranes into the cytoplasm and lysosomes. Vitamin B12 plays an important role in maintaining bone integrity and helps form new red blood cells in the bone marrow. B12 is arguably the most important factor in homocysteine metabolism, without which homocysteine levels can rise. Homocysteine can interfere with collagen cross linking and weaken bone matrix, increasing bone fragility. The famous Framingham Osteoporosis study from 1987 concluded low levels of homocysteine exist in people with osteoporosis

• Boron. This is involved in the conversion of Vitamin D to calcitriol and has an interactive role with calcium and magnesium. Boron is also needed to convert oestrogen into its most potent form, thereby prolonging the beneficial effects of oestrogen

• Vitamin K2, When Vitamin D is taken with calcium, Vitamin K2 should always be included as it is required to direct the calcium to the bones. Numerous studies have shown that vitamin K2 deficiency is associated with increased fracture risk. K2 supplementation reduces bone loss and fractures. Also, combined vitamin D3/K2  supplementation was demonstrated to be more effective in preventing bone loss than either alone

• Manganese. This stimulates the production of the organic bone matrix. Manganese deficiencies can result in abnormal cartilage formation. Studies in manganese deficient chicks showed problems with bone formation. The European Food Standards Agency ruled that “Manganese is needed for the structure of strong bones.”

• Silicon is high in hops and barley. It appears to act as a catalyst to make the bone calcify and then leaves so there is no harmful build up. Researchers found that short term supplementation with silicon improved bone mineral density in osteoporosis in animals

• Green tea. There is evidence suggesting that green tea helps to block the breakdown of bones as a result of chronic inflammatory processes caused by oxidative stress. The main bioactive component of green tea is epigallocatechin (EGCG). Research has shown that EGCG can improve bone density by enhancing bone building activity while suppressing bone breakdown. This results in enhanced mineralisation and decreased risk of fracture. Metabolics uses a powerful 90% EGCG Green tea in its formulations.

Metabolics’ OsteoAid is available online at £43.20 per 300 capsule pot.

Founded in 1993, Metabolics supplies nutritional supplements to a global client base of practitioners in a wide range of healthcare disciplines. Popular in the UK, US, Ireland and across Europe, Metabolics also has distributors in Greece, Singapore and Australia. In total, the company receives regular orders from over 20 countries around the world.

For further information, visit www.metabolics.com.

Ends

Editorial contact:

Emma De Maio
redheadPR
Tel: 07921 160 134
Email: emma@redheadpr.co.uk

Metabolics - Backgrounder

Formed in 1993, Metabolics is the UK’s premium quality supplement manufacturer. Popular in the UK, US, Ireland and across Europe, Metabolics also has distributors in Greece, Singapore and Australia. In total, the company receives regular orders from over 20 countries around the world.

Unlike many suppliers who bottle and market products manufactured overseas, Metabolics manufactures its supplements at its UK facility which was upgraded in 2011 to comprise state-of-the-art pharmaceutical clean room equipment.

Metabolics is one of very few manufacturers in the world that does not use binders, hidden fillers or flowing agents (machine lubricants) such as magnesium stearate during their production processes. Although these allow manufacturers to produce a low cost product, Metabolics believes that they compromise the quality of the supplement. Similarly, Metabolics only uses the best possible ingredients.

Manufacturing in the UK enables Metabolics to control and maintain their quality standards. The company is a comparatively small-volume manufacturer that manufactures on demand rather than producing large quantities of stock. This means that, as scientific knowledge of nutrition evolves, Metabolics can respond quickly with new product ranges.  This allows them to maintain their commitment to producing products which best reflect the latest scientific research.

Owned and run by original founder, Alison Astill-Smith, Metabolics has a dedicated workforce and enjoys a very low turnover of staff.  The company has ISO:9001 as well as ISO:14001 accreditation.  These standards recognise Metabolics’ quality management system and commitment to a pro-active environmental policy.

For more information, visit www.metabolics.com